Vitamin D toxicity

Last updated

Vitamin D toxicity
Cholecalciferol.svg
Cholecalciferol (shown above) and ergocalciferol are the two major forms of vitamin D.
Specialty Endocrinology, toxicology

Vitamin D toxicity, or hypervitaminosis D, is the toxic state of an excess of vitamin D. The normal range for blood concentration of 25-hydroxyvitamin D in adults is 20 to 50 nanograms per milliliter (ng/mL). Blood levels necessary to cause adverse effects in adults are thought to be greater than about 150 ng/mL, leading the Endocrine Society to suggest an upper limit for safety of 100 ng/mL. [1]

Contents

Signs and symptoms

An excess of vitamin D causes abnormally high blood concentrations of calcium, which can cause overcalcification of the bones, soft tissues, heart and kidneys. In addition, hypertension can result. [2] Symptoms of vitamin D toxicity may include the following:

Symptoms of vitamin D toxicity appear several months after excessive doses of vitamin D are administered. In almost every case, a low-calcium diet combined with corticosteroid drugs will allow for a full recovery within a month. It is possible that some of the symptoms of vitamin D toxicity are actually due to vitamin K depletion. One animal experiment has demonstrated that co-consumption with vitamin K reduced adverse effects, but this has not been tested in humans. [3] However the interconnected relationships between vitamin A, vitamin D, and vitamin K, outlined in a 2007 paper [4] published in the journal Medical Hypotheses, describes potential feedback loops between these three vitamins that could be elucidated by future research.

A mutation of the CYP24A1 gene can lead to a reduction in the degradation of vitamin D and to hypercalcemia (see Vitamin D: Excess).

The U.S National Academy of Medicine has established a Tolerable Upper Intake Level (UL) to protect against vitamin D toxicity ("The UL is not intended as a target intake; rather, the risk for harm begins to increase once intakes surpass this level."). [5] These levels in microgram (mcg or μg) and International Units (IU) for both males and females, by age, are:
(Conversion : 1  μg = 40 IU and 0.025 μg = 1 IU. [6] )

The recommended dietary allowance is 15 μg/d (600 IU per day; 800 IU for those over 70 years). Overdose has been observed at 1,925 μg/d (77,000 IU per day).[ citation needed ] Acute overdose requires between 15,000 μg/d (600,000 IU per day) and 42,000 μg/d (1,680,000 IU per day) over a period of several days to months.

Suggested tolerable upper intake level

Based on risk assessment, a safe upper intake level of 250 μg (10,000 IU) per day in healthy adults has been suggested by non-government authors. [7] [8] Blood levels of 25-hydroxyvitamin D necessary to cause adverse effects in adults are thought to be greater than about 150 ng/mL, leading the Endocrine Society to suggest an upper limit for safety of 100 ng/mL. [1]

Long-term effects of supplementary oral intake

Excessive exposure to sunlight poses no risk in vitamin D toxicity through overproduction of vitamin D precursor, cholecalciferol, regulating vitamin D production. During ultraviolet exposure, the concentration of vitamin D precursors produced in the skin reaches an equilibrium, and any further vitamin D that is produced is degraded. [9] This process is less efficient with increased melanin pigmentation in the skin. Endogenous production with full body exposure to sunlight is comparable to taking an oral dose between 250 μg and 625 μg (10,000 IU and 25,000 IU) per day. [9] [10]

Vitamin D oral supplementation and skin synthesis have a different effect on the transport form of vitamin D, plasma calcifediol concentrations. Endogenously synthesized vitamin D3 travels mainly with vitamin D-binding protein (DBP), which slows hepatic delivery of vitamin D and the availability in the plasma. [11] In contrast, orally administered vitamin D produces rapid hepatic delivery of vitamin D and increases plasma calcifediol. [11]

It has been questioned whether to ascribe a state of sub-optimal vitamin D status when the annual variation in ultraviolet will naturally produce a period of falling levels, and such a seasonal decline has been a part of Europeans' adaptive environment for 1000 generations. [12] [13] Still more contentious is recommending supplementation when those supposedly in need of it are labeled healthy and serious doubts exist as to the long-term effect of attaining and maintaining serum 25(OH)D of at least 80 nmol/L by supplementation. [14]

Current theories of the mechanism behind vitamin D toxicity (starting at a plasmatic concentration of ≈750 nmol/L [15] ) propose that:

All of these affect gene transcription and overwhelm the vitamin D signal transduction process, leading to vitamin D toxicity. [15]

Cardiovascular disease

Evidence suggests that dietary vitamin D may be carried by lipoprotein particles into cells of the artery wall and atherosclerotic plaque, where it may be converted to active form by monocyte-macrophages. [11] [16] [17] This raises questions regarding the effects of vitamin D intake on atherosclerotic calcification and cardiovascular risk as it may be causing vascular calcification. [18] Calcifediol is implicated in the etiology of atherosclerosis, especially in non-Whites. [19] [20]

The levels of the active form of vitamin D, calcitriol, are inversely correlated with coronary calcification. [21] Moreover, the active vitamin D analog, alfacalcidol, seems to protect patients from developing vascular calcification. [22] [23] Serum vitamin D has been found to correlate with calcified atherosclerotic plaque in African Americans as they have higher active serum vitamin D levels compared to Euro-Americans. [20] [24] [25] [26] Higher levels of calcidiol positively correlate with aorta and carotid calcified atherosclerotic plaque in African Americans but not with coronary plaque, whereas individuals of European descent have an opposite, negative association. [20] There are racial differences in the association of coronary calcified plaque in that there is less calcified atherosclerotic plaque in the coronary arteries of African-Americans than in whites. [27]

Among descent groups with heavy sun exposure during their evolution, taking supplemental vitamin D to attain the 25(OH)D level associated with optimal health in studies done with mainly European populations may have deleterious outcomes. [14] Despite abundant sunshine in India, vitamin D status in Indians is low and suggests a public health need to fortify Indian foods with vitamin D. However, the levels found in India are consistent with many other studies of tropical populations which have found that even an extreme amount of sun exposure, does not raise 25(OH)D levels to the levels typically found in Europeans. [28] [29] [30] [31]

Recommendations stemming for a single standard for optimal serum 25(OH)D concentrations ignores the differing genetically mediated determinates of serum 25(OH)D and may result in ethnic minorities in Western countries having the results of studies done with subjects not representative of ethnic diversity applied to them. Vitamin D levels vary for genetically mediated reasons as well as environmental ones. [32] [33] [34] [35]

Ethnic differences

Possible ethnic differences in physiological pathways for ingested vitamin D, such as the Inuit, may confound across the board recommendations for vitamin D levels. Inuit compensate for lower production of vitamin D by converting more of this vitamin to its most active form. [36]

Studies on the South Asian population uniformly point to low 25(OH)D levels, despite abundant sunshine. [37] Rural men around Delhi average 44 nmol/L. Healthy Indians seem to have low 25(OH)D levels which are not very different from healthy South Asians living in Canada. Measuring melanin content to assess skin pigmentation showed an inverse relationship with serum 25(OH)D. [38] The uniform occurrence of very low serum 25(OH)D in Indians living in India and Chinese in China does not support the hypothesis that the low levels seen in the more pigmented are due to lack of synthesis from the sun at higher latitudes.

Comparative Toxicity: Use of Vitamin D in Rodenticides

Vitamin D compounds, specifically cholecalciferol (D3) and ergocalciferol (D2), are used in rodenticides due to their ability to induce hypercalcemia, a condition characterized by elevated calcium levels in the blood. This overdose leads to organ failure and is pharmacologically similar to vitamin D's toxic effects in humans.

Concentrations used in these rodenticides are several orders of magnitude higher than the maximum recommended human intake, with acute baits containing 3,000,000 IU/g for D3 and 4,000,000 IU/g for D2. This leads to hypercalcemia in the rodents and subsequent death several days after ingestion. [39] [40]

See also

Related Research Articles

<span class="mw-page-title-main">Rickets</span> Childhood bone disorder

Rickets, scientific nomenclature: rachitis, is a condition that results in weak or soft bones in children and is caused by either dietary deficiency or genetic causes. Symptoms include bowed legs, stunted growth, bone pain, large forehead, and trouble sleeping. Complications may include bone deformities, bone pseudofractures and fractures, muscle spasms, or an abnormally curved spine. The analogous condition in adults is osteomalacia.

<span class="mw-page-title-main">Vitamin K</span> Fat-soluble vitamers

Vitamin K is a family of structurally similar, fat-soluble vitamers found in foods and marketed as dietary supplements. The human body requires vitamin K for post-synthesis modification of certain proteins that are required for blood coagulation or for controlling binding of calcium in bones and other tissues. The complete synthesis involves final modification of these so-called "Gla proteins" by the enzyme gamma-glutamyl carboxylase that uses vitamin K as a cofactor.

<span class="mw-page-title-main">7-Dehydrocholesterol</span> Chemical compound

7-Dehydrocholesterol (7-DHC) is a zoosterol that functions in the serum as a cholesterol precursor, and is photochemically converted to vitamin D3 in the skin, therefore functioning as provitamin-D3. The presence of this compound in human skin enables humans to manufacture vitamin D3 (cholecalciferol). Upon exposure to ultraviolet UV-B rays in the sun light, 7-DHC is converted into vitamin D3 via previtamin D3 as an intermediate isomer. It is also found in the milk of several mammalian species. Lanolin, a waxy substance that is naturally secreted by wool-bearing mammals, contains 7-DHC which is converted into vitamin D by sunlight and then ingested during grooming as a nutrient. In insects 7-dehydrocholesterol is a precursor for the hormone ecdysone, required for reaching adulthood. 7-DHC was discovered by Nobel-laureate organic chemist Adolf Windaus.

Tocopherols are a class of organic compounds comprising various methylated phenols, many of which have vitamin E activity. Because the vitamin activity was first identified in 1936 from a dietary fertility factor in rats, it was named tocopherol, from Greek τόκοςtókos 'birth' and φέρεινphérein 'to bear or carry', that is 'to carry a pregnancy', with the ending -ol signifying its status as a chemical alcohol.

<span class="mw-page-title-main">Atherosclerosis</span> Inflammatory disease involving buildup of lesions in the walls of arteries

Atherosclerosis is a pattern of the disease arteriosclerosis, characterized by development of abnormalities called lesions in walls of arteries. This is a chronic inflammatory disease involving many different cell types and driven by elevated levels of cholesterol in the blood. These lesions may lead to narrowing of the arterial walls due to buildup of atheromatous plaques. At the onset there are usually no symptoms, but if they develop, symptoms generally begin around middle age. In severe cases, it can result in coronary artery disease, stroke, peripheral artery disease, or kidney disorders, depending on which body part(s) the affected arteries are located in the body.

<span class="mw-page-title-main">Cholecalciferol</span> Vitamin D3, a chemical compound

Cholecalciferol, also known as vitamin D3 or colecalciferol, is a type of vitamin D that is produced by the skin when exposed to UVB light; it is found in certain foods and can be taken as a dietary supplement.

<span class="mw-page-title-main">Ergocalciferol</span> Vitamin D2, a chemical compound

Ergocalciferol, also known as vitamin D2 and nonspecifically calciferol, is a type of vitamin D found in food. It is used as a dietary supplement to prevent and treat vitamin D deficiency due to poor absorption by the intestines or liver disease. It may also be used for low blood calcium due to hypoparathyroidism. It is taken by mouth or via injection into a muscle.

<span class="mw-page-title-main">Osteomalacia</span> Softening of bones due to impaired bone metabolism

Osteomalacia is a disease characterized by the softening of the bones caused by impaired bone metabolism primarily due to inadequate levels of available phosphate, calcium, and vitamin D, or because of resorption of calcium. The impairment of bone metabolism causes inadequate bone mineralization.

β-Carotene Red-orange pigment of the terpenoids class

β-Carotene (beta-carotene) is an organic, strongly colored red-orange pigment abundant in fungi, plants, and fruits. It is a member of the carotenes, which are terpenoids (isoprenoids), synthesized biochemically from eight isoprene units and thus having 40 carbons.

<span class="mw-page-title-main">Calcitriol</span> Active form of vitamin D

Calcitriol is a hormone and the active form of vitamin D, normally made in the kidney. It is also known as 1,25-dihydroxycholecalciferol. It binds to and activates the vitamin D receptor in the nucleus of the cell, which then increases the expression of many genes. Calcitriol increases blood calcium mainly by increasing the uptake of calcium from the intestines.

<span class="mw-page-title-main">Hypervitaminosis A</span> Toxic effects of ingesting too much vitamin A

Hypervitaminosis A refers to the toxic effects of ingesting too much preformed vitamin A. Symptoms arise as a result of altered bone metabolism and altered metabolism of other fat-soluble vitamins. Hypervitaminosis A is believed to have occurred in early humans, and the problem has persisted throughout human history. Toxicity results from ingesting too much preformed vitamin A from foods, supplements, or prescription medications and can be prevented by ingesting no more than the recommended daily amount.

<span class="mw-page-title-main">Nutrition and pregnancy</span> Nutrient intake and dietary planning undertaken before, during and after pregnancy

Nutrition and pregnancy refers to the nutrient intake, and dietary planning that is undertaken before, during and after pregnancy. Nutrition of the fetus begins at conception. For this reason, the nutrition of the mother is important from before conception as well as throughout pregnancy and breastfeeding. An ever-increasing number of studies have shown that the nutrition of the mother will have an effect on the child, up to and including the risk for cancer, cardiovascular disease, hypertension and diabetes throughout life.

<span class="mw-page-title-main">Calcifediol</span> Chemical compound

Calcifediol, also known as calcidiol, 25-hydroxycholecalciferol, or 25-hydroxyvitamin D3 (abbreviated 25(OH)D3), is a form of vitamin D produced in the liver by hydroxylation of vitamin D3 (cholecalciferol) by the enzyme vitamin D 25-hydroxylase. Calcifediol can be further hydroxylated by the enzyme 25(OH)D-1α-hydroxylase, primarily in the kidney, to form calcitriol (1,25-(OH)2D3), which is the active hormonal form of vitamin D.

<span class="mw-page-title-main">CYP2R1</span> Mammalian protein found in Homo sapiens

CYP2R1 is cytochrome P450 2R1, an enzyme which is the principal vitamin D 25-hydroxylase. In humans it is encoded by the CYP2R1 gene located on chromosome 11p15.2. It is expressed in the endoplasmic reticulum in liver, where it performs the first step in the activation of vitamin D by catalyzing the formation of 25-hydroxyvitamin D.

Selenium deficiency occurs when an organism lacks the required levels of selenium, a critical nutrient in many species. Deficiency, although relatively rare in healthy well-nourished individuals, can have significant negative results, affecting the health of the heart and the nervous system; contributing to depression, anxiety, and dementia; and interfering with reproduction and gestation.

<span class="mw-page-title-main">Vitamin D deficiency</span> Human disorder

Vitamin D deficiency or hypovitaminosis D is a vitamin D level that is below normal. It most commonly occurs in people when they have inadequate exposure to sunlight, particularly sunlight with adequate ultraviolet B rays (UVB). Vitamin D deficiency can also be caused by inadequate nutritional intake of vitamin D; disorders that limit vitamin D absorption; and disorders that impair the conversion of vitamin D to active metabolites, including certain liver, kidney, and hereditary disorders. Deficiency impairs bone mineralization, leading to bone-softening diseases, such as rickets in children. It can also worsen osteomalacia and osteoporosis in adults, increasing the risk of bone fractures. Muscle weakness is also a common symptom of vitamin D deficiency, further increasing the risk of fall and bone fractures in adults. Vitamin D deficiency is associated with the development of schizophrenia.

<span class="mw-page-title-main">Vitamin D</span> Group of fat-soluble secosteroids

Vitamin D is a group of fat-soluble secosteroids responsible for increasing intestinal absorption of calcium, magnesium, and phosphate, along with numerous other biological functions. In humans, the most significant compounds within this group are vitamin D3 (cholecalciferol) and vitamin D2 (ergocalciferol).

<span class="mw-page-title-main">Selenium in biology</span> Use of Selenium by organisms

Selenium is an essential micronutrient for animals, though it is toxic in large doses. In plants, it sometimes occurs in toxic amounts as forage, e.g. locoweed. Selenium is a component of the amino acids selenocysteine and selenomethionine. In humans, selenium is a trace element nutrient that functions as cofactor for glutathione peroxidases and certain forms of thioredoxin reductase. Selenium-containing proteins are produced from inorganic selenium via the intermediacy of selenophosphate (PSeO33−).

Vitamin K<sub>2</sub> Group of vitamins and bacterial metabolites

Vitamin K2 or menaquinone (MK) is one of three types of vitamin K, the other two being vitamin K1 (phylloquinone) and K3 (menadione). K2 is both a tissue and bacterial product (derived from vitamin K1 in both cases) and is usually found in animal products or fermented foods.

<span class="mw-page-title-main">Vegetarian and vegan dog diet</span> Adequate meat-free or animal-free nutrition

As in the human practice of veganism, vegan dog foods are those formulated with the exclusion of ingredients that contain or were processed with any part of an animal, or any animal byproduct. Vegan dog food may incorporate the use of fruits, vegetables, cereals, legumes including soya, nuts, vegetable oils, as well as any other non-animal based foods.

References

  1. 1 2 Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011). "Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline". J Clin Endocrinol Metab. 96 (7): 1922. doi: 10.1210/jc.2011-0385 . PMID   21646368. S2CID   13662494.
  2. ↑ Vitamin D at The Merck Manual of Diagnosis and Therapy Professional Edition
  3. ↑ Elshama SS, et al. (2016). "Comparison between the protective effects of vitamin K and vitamin A on the modulation of hypervitaminosis D3 short-term toxicity in adult albino rats". Turk J Med Sci. 46 (2): 524–38. doi: 10.3906/sag-1411-6 . PMID   27511521.
  4. ↑ Masterjohn C (2007). "Vitamin D toxicity redefined: Vitamin K and the molecular mechanism". Medical Hypotheses. 68 (5): 1026–34. doi:10.1016/j.mehy.2006.09.051. PMID   17145139.
  5. ↑ Ross, et al. (2010). "The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know". J Clin Endocrinol Metab. 96 (1): 53–58. doi:10.1210/jc.2010-2704. PMC   3046611 . PMID   21118827.
  6. ↑ "Dietary Reference Intakes Tables [Health Canada, 2005]". Archived from the original on July 21, 2011. Retrieved July 21, 2011.
  7. ↑ Hathcock JN, Shao A, Vieth R, Heaney R (January 2007). "Risk assessment for vitamin D". The American Journal of Clinical Nutrition. 85 (1): 6–18. doi: 10.1093/ajcn/85.1.6 . PMID   17209171.
  8. ↑ Vieth R (December 2007). "Vitamin D toxicity, policy, and science". Journal of Bone and Mineral Research. 22 (Suppl 2): V64-8. doi: 10.1359/jbmr.07s221 . PMID   18290725. S2CID   24460808.
  9. 1 2 Holick MF (March 1995). "Environmental factors that influence the cutaneous production of vitamin D". The American Journal of Clinical Nutrition. 61 (3 Suppl): 638S–645S. doi: 10.1093/ajcn/61.3.638S . PMID   7879731.
  10. ↑ [Effects Of Vitamin D and the Natural selection of skin color:how much vitamin D nutrition are we talking about http://www.direct-ms.org/pdf/VitDVieth/Vieth%20Anthropology%20vit%20D.pdf][ full citation needed ]
  11. 1 2 3 Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J (June 1993). "Human plasma transport of vitamin D after its endogenous synthesis". The Journal of Clinical Investigation. 91 (6): 2552–5. doi:10.1172/JCI116492. PMC   443317 . PMID   8390483.
  12. ↑ Kull M, Kallikorm R, Tamm A, Lember M (January 2009). "Seasonal variance of 25-(OH) vitamin D in the general population of Estonia, a Northern European country". BMC Public Health. 9: 22. doi: 10.1186/1471-2458-9-22 . PMC   2632995 . PMID   19152676.
  13. ↑ Hoffecker JF (September 2009). "Out of Africa: modern human origins special feature: the spread of modern humans in Europe". Proceedings of the National Academy of Sciences of the United States of America. 106 (38): 16040–5. Bibcode:2009PNAS..10616040H. doi: 10.1073/pnas.0903446106 . JSTOR   40485016. PMC   2752585 . PMID   19571003.
  14. 1 2 Tseng L (2003). "Controversies in Vitamin D Supplementation". Nutrition Bytes. 9 (1).
  15. 1 2 Jones G (August 2008). "Pharmacokinetics of vitamin D toxicity". The American Journal of Clinical Nutrition. 88 (2): 582S–586S. doi: 10.1093/ajcn/88.2.582s . PMID   18689406.
  16. ↑ Hsu JJ, Tintut Y, Demer LL (September 2008). "Vitamin D and osteogenic differentiation in the artery wall". Clinical Journal of the American Society of Nephrology. 3 (5): 1542–7. doi:10.2215/CJN.01220308. PMC   4571147 . PMID   18562594.
  17. ↑ Speeckaert MM, Taes YE, De Buyzere ML, Christophe AB, Kaufman JM, Delanghe JR (March 2010). "Investigation of the potential association of vitamin D binding protein with lipoproteins". Annals of Clinical Biochemistry. 47 (Pt 2): 143–50. doi: 10.1258/acb.2009.009018 . PMID   20144976.
  18. ↑ Demer LL, Tintut Y (June 2008). "Vascular calcification: pathobiology of a multifaceted disease". Circulation. 117 (22): 2938–48. doi:10.1161/CIRCULATIONAHA.107.743161. PMC   4431628 . PMID   18519861.
  19. ↑ Fraser DR (April 1983). "The physiological economy of vitamin D". Lancet. 1 (8331): 969–72. doi:10.1016/S0140-6736(83)92090-1. PMID   6132277. S2CID   31392498.
  20. 1 2 3 Freedman BI, Wagenknecht LE, Hairston KG, Bowden DW, Carr JJ, Hightower RC, Gordon EJ, Xu J, Langefeld CD, Divers J (March 2010). "Vitamin d, adiposity, and calcified atherosclerotic plaque in african-americans". The Journal of Clinical Endocrinology and Metabolism. 95 (3): 1076–83. doi:10.1210/jc.2009-1797. PMC   2841532 . PMID   20061416.
  21. ↑ Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, Demer LL (September 1997). "Active serum vitamin D levels are inversely correlated with coronary calcification". Circulation. 96 (6): 1755–60. doi:10.1161/01.cir.96.6.1755. PMID   9323058. S2CID   25969870.
  22. ↑ Brandi L (November 2008). "1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis". Danish Medical Bulletin. 55 (4): 186–210. PMID   19232159.
  23. ↑ Ogawa T, Ishida H, Akamatsu M, Matsuda N, Fujiu A, Ito K, Ando Y, Nitta K (January 2010). "Relation of oral 1alpha-hydroxy vitamin D3 to the progression of aortic arch calcification in hemodialysis patients". Heart and Vessels. 25 (1): 1–6. doi:10.1007/s00380-009-1151-4. PMID   20091391. S2CID   10713786.
  24. ↑ Bell NH, Greene A, Epstein S, Oexmann MJ, Shaw S, Shary J (August 1985). "Evidence for alteration of the vitamin D-endocrine system in blacks". The Journal of Clinical Investigation. 76 (2): 470–3. doi:10.1172/JCI111995. PMC   423843 . PMID   3839801.
  25. ↑ Cosman F, Nieves J, Dempster D, Lindsay R (December 2007). "Vitamin D economy in blacks". Journal of Bone and Mineral Research. 22 (Suppl 2): V34-8. doi: 10.1359/jbmr.07s220 . PMID   18290719. S2CID   5251285.
  26. ↑ Dawson-Hughes B (December 2004). "Racial/ethnic considerations in making recommendations for vitamin D for adult and elderly men and women". The American Journal of Clinical Nutrition. 80 (6 Suppl): 1763S–6S. doi: 10.1093/ajcn/80.6.1763S . PMID   15585802.
  27. ↑ Tang W, Arnett DK, Province MA, Lewis CE, North K, Carr JJ, Pankow JS, Hopkins PN, Devereux RB, Wilk JB, Wagenknecht L (May 2006). "Racial differences in the association of coronary calcified plaque with left ventricular hypertrophy: the National Heart, Lung, and Blood Institute Family Heart Study and Hypertension Genetic Epidemiology Network". The American Journal of Cardiology. 97 (10): 1441–8. doi:10.1016/j.amjcard.2005.11.076. PMID   16679080.
  28. ↑ Goswami R, Kochupillai N, Gupta N, Goswami D, Singh N, Dudha A (October 2008). "Presence of 25(OH) D deficiency in a rural North Indian village despite abundant sunshine". The Journal of the Association of Physicians of India. 56: 755–7. PMID   19263699.
  29. ↑ Lips P (July 2010). "Worldwide status of vitamin D nutrition". The Journal of Steroid Biochemistry and Molecular Biology. 121 (1–2): 297–300. doi:10.1016/j.jsbmb.2010.02.021. PMID   20197091. S2CID   8795644.
  30. ↑ Schoenmakers I, Goldberg GR, Prentice A (June 2008). "Abundant sunshine and vitamin D deficiency". The British Journal of Nutrition. 99 (6): 1171–3. doi:10.1017/S0007114508898662. PMC   2758994 . PMID   18234141.
  31. ↑ Hagenau T, Vest R, Gissel TN, Poulsen CS, Erlandsen M, Mosekilde L, Vestergaard P (January 2009). "Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis". Osteoporosis International. 20 (1): 133–40. doi:10.1007/s00198-008-0626-y. PMID   18458986. S2CID   3150030.
  32. ↑ Engelman CD, Fingerlin TE, Langefeld CD, Hicks PJ, Rich SS, Wagenknecht LE, Bowden DW, Norris JM (September 2008). "Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans". The Journal of Clinical Endocrinology and Metabolism. 93 (9): 3381–8. doi:10.1210/jc.2007-2702. PMC   2567851 . PMID   18593774.
  33. ↑ Creemers PC, Du Toit ED, Kriel J (December 1995). "DBP (vitamin D binding protein) and BF (properdin factor B) allele distribution in Namibian San and Khoi and in other South African populations". Gene Geography. 9 (3): 185–9. PMID   8740896.
  34. ↑ Lips P (March 2007). "Vitamin D status and nutrition in Europe and Asia". The Journal of Steroid Biochemistry and Molecular Biology. 103 (3–5): 620–5. doi:10.1016/j.jsbmb.2006.12.076. PMID   17287117. S2CID   21295091.
  35. ↑ Borges CR, Rehder DS, Jarvis JW, Schaab MR, Oran PE, Nelson RW (February 2010). "Full-length characterization of proteins in human populations". Clinical Chemistry. 56 (2): 202–11. doi:10.1373/clinchem.2009.134858. PMID   19926773. S2CID   1407188.
  36. ↑ Rejnmark L, Jørgensen ME, Pedersen MB, Hansen JC, Heickendorff L, Lauridsen AL, Mulvad G, Siggaard C, Skjoldborg H, Sørensen TB, Pedersen EB, Mosekilde L (March 2004). "Vitamin D insufficiency in Greenlanders on a westernized fare: ethnic differences in calcitropic hormones between Greenlanders and Danes". Calcified Tissue International. 74 (3): 255–63. doi:10.1007/s00223-003-0110-9. PMID   14708040. S2CID   2887272.
  37. ↑ "Vitamin D Status in India – Its Implications and Remedial Measures". psu.edu. Retrieved January 26, 2023.
  38. ↑ Gozdzik A, Barta JL, Wu H, Wagner D, Cole DE, Vieth R, Whiting S, Parra EJ (September 2008). "Low wintertime vitamin D levels in a sample of healthy young adults of diverse ancestry living in the Toronto area: associations with vitamin D intake and skin pigmentation". BMC Public Health. 8: 336. doi: 10.1186/1471-2458-8-336 . PMC   2576234 . PMID   18817578.
  39. ↑ CHOLECALCIFEROL: A UNIQUE TOXICANT FOR RODENT CONTROL. Proceedings of the Eleventh Vertebrate Pest Conference (1984). University of Nebraska Lincoln. March 1984. Archived from the original on August 27, 2019. Cholecalciferol is an acute (single-feeding) and/or chronic (multiple-feeding) rodenticide toxicant with unique activity for controlling commensal rodents including anticoagulant-resistant rats. Cholecalciferol differs from conventional acute rodenticides in that no bait shyness is associated with consumption and time to death is delayed, with first dead rodents appearing 3-4 days after treatment.
  40. ↑ Rizor SE, Arjo WM, Bulkin S, Nolte DL. Efficacy of Cholecalciferol Baits for Pocket Gopher Control and Possible Effects on Non-Target Rodents in Pacific Northwest Forests. Vertebrate Pest Conference (2006). USDA. Archived from the original on September 14, 2012. Retrieved August 27, 2019. 0.15% cholecalciferol bait appears to have application for pocket gopher control.' Cholecalciferol can be a single high-dose toxicant or a cumulative multiple low-dose toxicant.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.